At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
EUDA EUDA Health Holdings Limited
Closed 11-02 16:00:00 EST
15.57
-2.13
-12.03%
盘后15.57
+0.000.00%
19:30 EST
High17.41Low15.57Vol87.06K
Open17.00D1 Closing17.70Amplitude10.40%
Mkt Cap46.62MTradable Cap27.43MTotal Shares2.99M
T/O1.43MT/O Rate4.94%Tradable Shares1.76M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Euda Health Net Loss Narrows to $796,950 in Six Months Ended June 30, 2026; Revenue Rises 13% to $3.47 Million
Reuters  ·  09-30
Euda Health Net Loss Narrows to $796,950 in Six Months Ended June 30, 2026; Revenue Rises 13% to $3.47 Million
EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore
GlobeNewswire  ·  08-26
EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore
EUDA Health, GO POSB, Shenzhen Innovation Plan Cell Therapy Collaboration
MT Newswires Live  ·  07-30
EUDA Health, GO POSB, Shenzhen Innovation Plan Cell Therapy Collaboration
EUDA Health Signs MOU with GO POSB, SIIT to Develop Off-the-shelf iPSC Cell Therapies
Reuters  ·  07-30
EUDA Health Signs MOU with GO POSB, SIIT to Develop Off-the-shelf iPSC Cell Therapies
EUDA Health Announces Collaboration to Advance an Integrated Ipsc Cell Therapy Program for Oncology and Wellness • Targets Global Distribution for Innovative Oncology Products
THOMSON REUTERS  ·  07-30
EUDA Health Announces Collaboration to Advance an Integrated Ipsc Cell Therapy Program for Oncology and Wellness • Targets Global Distribution for Innovative Oncology Products
EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
GlobeNewswire  ·  07-30
EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
EUDA Health Signs Tri-Party MOU to Develop Next-Generation Oncology Cell Therapies
TIPRANKS  ·  07-29
EUDA Health Signs Tri-Party MOU to Develop Next-Generation Oncology Cell Therapies
EUDA Health Signs MOU With GO POSB Organoids, Shenzhen Inno on Induced Pluripotent Stem Cell Therapies
MT Newswires Live  ·  07-28
EUDA Health Signs MOU With GO POSB Organoids, Shenzhen Inno on Induced Pluripotent Stem Cell Therapies
EUDA Health signs MoU with GO POSB Organoids, SIIT
TIPRANKS  ·  07-28
EUDA Health signs MoU with GO POSB Organoids, SIIT
EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
GlobeNewswire  ·  07-28
EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
EUDA Health Holdings Ltd trading resumes
TIPRANKS  ·  07-14
EUDA Health Holdings Ltd trading resumes
NASDAQ Trade Halt Volatility Trading Pause at 10:19 Am
Reuters  ·  07-14
NASDAQ Trade Halt Volatility Trading Pause at 10:19 Am
EUDA Health Halts and Moves to Terminate $10 Million ATM Equity Program
TIPRANKS  ·  06-10
EUDA Health Halts and Moves to Terminate $10 Million ATM Equity Program
Euda Health suspends $10 million at-the-market share offering ahead of termination of Chardan agreement
Reuters  ·  06-10
Euda Health suspends $10 million at-the-market share offering ahead of termination of Chardan agreement
EUDA Health regains Nasdaq compliance
TIPRANKS  ·  06-01
EUDA Health regains Nasdaq compliance
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
GlobeNewswire  ·  06-01
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
Euda Health regains Nasdaq compliance after market value falls below $35 million threshold
Reuters  ·  06-01
Euda Health regains Nasdaq compliance after market value falls below $35 million threshold
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
GlobeNewswire  ·  06-01
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
EUDA Health Holdings Ltd trading resumes
TIPRANKS  ·  05-07
EUDA Health Holdings Ltd trading resumes
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:44 AM
Reuters  ·  05-06
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:44 AM

Introduction

Company Name.
EUDA Health Holdings Limited
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
8I Acquisition 2 Corp. is a blank check company. Its purpose is to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated on January 21, 2021, and is headquartered in Singapore.
Issue price:
--